SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0000950159-14-000072
Filing Date
2014-02-13
Accepted
2014-02-13 13:56:25
Documents
1
Group Members
QUAKER BIOVENTURES CAPITAL II L.P.QUAKER BIOVENTURES CAPITAL II LLC

Document Format Files

Seq Description Document Type Size
1 QUAKER BIOVENTURES II, L.P. FORM SC 13G/A sc13g.htm SC 13G/A 118166
  Complete submission text file 0000950159-14-000072.txt   119816
Mailing Address QUAKER BIOVENTURES 2929 ARCH STREET PHILADELPHIA PA 19104
Business Address QUAKER BIOVENTURES 2929 ARCH STREET PHILADELPHIA PA 19104 (215) 988-6800
Quaker BioVentures II LP (Filed by) CIK: 0001497725 (see all company filings)

IRS No.: 205328033 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 200 SOUTH WACKER DRIVE SUITE 2550 CHICAGO IL 60606
Business Address 200 SOUTH WACKER DRIVE SUITE 2550 CHICAGO IL 60606 312-219-7000
Durata Therapeutics, Inc. (Subject) CIK: 0001544116 (see all company filings)

IRS No.: 871247903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-86923 | Film No.: 14604913
SIC: 2834 Pharmaceutical Preparations